Cangzhou Senary Chemical Science Tech Co Ltd | IERZZGXDUZIMSC-PBDVDRNWSA-N | Suppliers | Manufacturers & Suppliers

Also known as: 1210348-34-7, Tert-butyl n-[(1r,2s,5s)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate oxalate, Tert-butyl [(1r,2s,5s)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate, Tert-butyl n-[(1r,2s,5s)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate;oxalic acid, Tert - butyl [(1r,2s,5s) - 2 - amino - 5 - [(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate, Tert-butyl ((1r,2s,5s)-2-amino-5-((dimethylamino)carbonyl)cyclohexyl)carbamate oxalate

Molecular Formula

C₁₆H₂₉N₃O₇

Molecular Weight

375.42 g/mol

InChI Key

IERZZGXDUZIMSC-PBDVDRNWSA-N

1 2D Structure

IERZZGXDUZIMSC-PBDVDRNWSA-N

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate;oxalic acid

2.1.2 InChI

InChI=1S/C14H27N3O3.C2H2O4/c1-14(2,3)20-13(19)16-11-8-9(6-7-10(11)15)12(18)17(4)5;3-1(4)2(5)6/h9-11H,6-8,15H2,1-5H3,(H,16,19);(H,3,4)(H,5,6)/t9-,10-,11+;/m0./s1

2.1.3 InChI Key

IERZZGXDUZIMSC-PBDVDRNWSA-N

2.1.4 Canonical SMILES

CC(C)(C)OC(=O)NC1CC(CCC1N)C(=O)N(C)C.C(=O)(C(=O)O)O

2.1.5 Isomeric SMILES

CC(C)(C)OC(=O)N[C@@H]1C[C@H](CC[C@@H]1N)C(=O)N(C)C.C(=O)(C(=O)O)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1210348-34-7

2. Tert-butyl N-[(1r,2s,5s)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate Oxalate

3. Tert-butyl [(1r,2s,5s)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate Oxalate

4. Tert-butyl N-[(1r,2s,5s)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate;oxalic Acid

5. Tert - Butyl [(1r,2s,5s) - 2 - Amino - 5 - [(dimethylamino)carbonyl]cyclohexyl]carbamate Oxalate

6. Tert-butyl ((1r,2s,5s)-2-amino-5-((dimethylamino)carbonyl)cyclohexyl)carbamate Oxalate

7. Tert-butyl {(1r,2s,5s)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl}carbamate Oxalate

8. Ethanediamide Impurity A

9. Amy19407

10. Cs-m3400

11. Mfcd28501698

12. Akos025289771

13. Ds-7605

14. Tert-butyl[(1r,2s,5s)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate Oxalate

15. P15585

16. A851763

17. T-butyl {(1r,2s,5s)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl}carbamate Oxalate

18. Tert-butyl((1r,2s,5s)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamateoxalate

19. Tert-butyl(1r,2s,5s)-2-amino-5-[(dimethylamino)carbonyl]cyclohexylcarbamate Oxalate

2.3 Create Date

2010-10-18

3 Chemical and Physical Properties

Molecular Formula	C₁₆H₂₉N₃O₇
Molecular Weight	375.42 g/mol
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	5
Exact Mass	375.20055027 g/mol
Monoisotopic Mass	375.20055027 g/mol
Topological Polar Surface Area	159 Å²
Heavy Atom Count	26
Formal Charge	0
Complexity	435
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Cangzhou Senary Chemical Science-te...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

Tert-butyl(1R, 2S, 5S)-2-amino-5-((dimethylamino)carbon...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1210348-34-7

End Use API

Edoxaban Tosylate

About the Company

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.

ASK
US